Press release
Monoclonal Antibody Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity
Monoclonal Antibody Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity
Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Monoclonal Antibody Market Research Report: https://marketgenics.co/press-releases/monoclonal-antibody-market-76573
Global Monoclonal Antibody Market Forecast 2035:
According to the report, the global monoclonal antibody market is likely to grow from USD 237.5 Billion in 2025 to USD 750.9 Billion in 2035 at a highest CAGR of 12.2% during the time period. The worldwide monoclonal antibody marketplace is experiencing a rapid growth due to growing clinical success rates, technological advancement and the growing prevalence of chronic and autoimmune diseases worldwide. Biologic-based therapeutics and increased personalized medicine have transformed the outcomes of therapeutic response and are rapidly being adopted in oncology, immunology, and infectious disease settings.
In March, 2024, AbbVie announced the diversification of its antibody base, by developing new immunomodulatory treatment of autoimmune disease, which solidifies the leadership of the company in the biologics field. Equally, Amgen in April 2024 took the next-generation bispecific antibody, tarlatamab, into late-stage clinical trials in small cell lung cancer, reflecting the rising trend of precision-based oncology solutions. Besides, antibody design and scalability are being improved by more collaborations between biotech companies and research institutions. This growth is also maintained by the increase in government and private investment in the manufacturing infrastructure of biologics.
"Key Driver, Restraint, and Growth Opportunity Shaping the Global Monoclonal Antibody Market
The monoclonal antibody market is strongly being driven by the growing clinical usage of antibody-drug conjugates (ADCs). ADCs are complementing the precision of cancer treatment with their capability of delivering specific cytotoxic drugs. As an example, in February 2024, Enhertu has been issued by AstraZeneca to expand into the HER2-low breast cancer, which strengthens the move toward targeted biologics.
The manufacturing and purification cost remain high, and it is still a challenge to the market scalability. The complicated upstream procedures and cold-chain logistics restrict the affordability and accessibility, especially in the developing areas. The 2024 production reorganization by Roche emphasizes that the cost optimization is one of the bottlenecks to the expansion of biologics.
The increasing penetration of artificial intelligence-based antibody discovery systems is generating immense potentials of speedy drug development. At the beginning of 2024, Sanofi collaborated with Exscientia to create new therapeutic antibodies by design through AI, which allowed reducing the time of candidate identification and shortening the timeframes of the initial stages of development.
To know more about the Monoclonal Antibody Market - Download our Sample Report: https://marketgenics.co/download-report-sample/monoclonal-antibody-market-76573
Regional Analysis of Global Monoclonal Antibody Market
North America has the highest demand of monoclonal antibodies because of the high biopharmaceutical infrastructure, much investment on research and development, and quick regulatory approvals of novel therapies. The region is dominated by innovations, and in January 2024, Regeneron Pharmaceuticals got U.S. FDA approval of Veopoz, a monoclonal antibody targeting CHAPLE disease. North America has been leading due to high levels of therapeutic innovation and strong commercialization ecosystem.
Asia Pacific is experiencing the most rapid growth because of massive investment in biologics manufacturing and access to the latest immunotherapies is increasing. In 2024, WuXi Biologics increased its antibody manufacturing plant in china to increase local production and exporting capacity.
The development of Europe is propelled by the incorporation of sustainable bioproduction and precision medicine plans. Novartis established a new antibody research center in Switzerland in 2024, which reinforced the development of clinical pipelines.
Prominent players operating in the global monoclonal antibody market are AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., GlaxoSmithKline plc (GSK), Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, UCB S.A., and Other Key Players.
Buy Now: https://marketgenics.co/buy/monoclonal-antibody-market-76573
The global monoclonal antibody market has been segmented as follows:
Global Monoclonal Antibody Market Analysis, by Product Type
Murine Antibodies
Chimeric Antibodies
Humanized Antibodies
Fully Human Antibodies
Bispecific Antibodies
Antibody-Drug Conjugates (ADCs)
Biosimilar Monoclonal Antibodies
Global Monoclonal Antibody Market Analysis, by Source
Mouse
Rabbit
Chimeric
Humanized
Human
Others
Global Monoclonal Antibody Market Analysis, by Production Method
Hybridoma Technology
Recombinant DNA Technology
Phage Display Technology
Transgenic Mice Technology
Single B Cell Technology
Global Monoclonal Antibody Market Analysis, by Indication
Oncology
Breast Cancer
Lung Cancer
Colorectal Cancer
Lymphoma
Leukemia
Multiple Myeloma
Others
Autoimmune Diseases
Rheumatoid Arthritis
Psoriasis
Crohn's Disease
Multiple Sclerosis
Lupus
Others
Infectious Diseases
HIV/AIDS
COVID-19
Respiratory Syncytial Virus (RSV)
Others
Cardiovascular Diseases
Ophthalmology
Hematology
Neurology
Respiratory Diseases
Global Monoclonal Antibody Market Analysis, by Molecule Type
IgG1
IgG2
IgG4
IgA
IgM
IgE
Global Monoclonal Antibody Market Analysis, by Mode of Action
Signal Transduction Inhibitors
Cell Death Inducers
Angiogenesis Inhibitors
Immune Checkpoint Modulators
Targeted Drug Delivery
Global Monoclonal Antibody Market Analysis, by Route of Administration
Intravenous (IV)
Subcutaneous (SC)
Intramuscular (IM)
Global Monoclonal Antibody Market Analysis, by End-users
Hospitals & Clinics
Cancer Treatment
Autoimmune Disease Management
Infectious Disease Treatment
Transplant Rejection Prevention
Emergency Care
Others
Research & Academic Institutes
Drug Discovery
Biomarker Identification
Disease Mechanism Studies
Preclinical Research
Clinical Trials
Others
Pharmaceutical & Biotechnology Companies
Drug Development
Manufacturing
Quality Control
Biosimilar Development
Contract Manufacturing
Others
Diagnostic Laboratories
Disease Diagnosis
Biomarker Testing
Companion Diagnostics
Immunoassays
Flow Cytometry
Others
Contract Research Organizations (CROs)
Ambulatory Surgical Centers
Blood Banks & Transfusion Centers
Other End-users
Global Monoclonal Antibody Market Analysis, by Region
North America
Europe
Asia Pacific
Middle East
Africa
South America
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Monoclonal Antibody Market Forecast 2035 | Key Driver, Restraint, and Growth Opportunity here
News-ID: 4274014 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
APAC Deepfake Detection Market Accelerates as Governments Tighten Digital Trust …
A Market Transforming How the World Verifies Reality
The global deepfake detection technology market, valued at USD 0.6 billion in 2025, is positioned to accelerate at a powerful 37.2% CAGR, reaching USD 15.1 billion by 2035.
This growth is driven by one undeniable truth:
Synthetic media is reshaping the threat landscape faster than humans can recognize it.
Deepfake detection technologies now determine:
How newsrooms verify breaking content
How financial institutions prevent identity-spoofing
How governments protect election integrity
How…
Travel & Expense Management Software Market Signals a Digital Pivot | AI, Cloud …
The Travel and Expense Management (TEM) Market Crossroads | A Sector Accelerating, Repricing Efficiency, and Redrawing the Corporate Spend Map
(Is TEM a Back-Office Tool-or the Operating System of the Next Enterprise Economy?)
For years, the travel and expense management software market lived in the administrative shadows-handed off to finance teams, constrained by spreadsheets, and dismissed as a routine cost-control tool. But the numbers now tell a radically different story.
In 2025, the…
Oilfield Equipment Market hits USD 116.2B in 2025 and grows to USD 156.5B by 203 …
Oilfield Equipment Market | The $156.5B Hardware Backbone of the Global Energy System
Every headline loves clean energy. Yet the global energy mix still demands a brutal truth: oil and gas remain the world's primary supply of heat, mobility, and petrochemicals - and the machines that drill, lift, complete, and produce hydrocarbons continue to define industrial capability.
That's why the Oilfield Equipment Market remains a strategic industry - not a relic.
In 2025,…
Machine Tools Market 2025-2035 | USD 109.9B Growth, CNC & Automation Trends
Machine Tools Market | The $109.9B Intelligence Engine of Global Manufacturing
Factories don't work without machine tools. They shape, cut, drill, grind, and define the physical world around us. Yet most end-products - cars, aircraft parts, electronics housings, surgical devices - never reveal the precision machinery behind them.
The Machine Tools Market is the invisible infrastructure that turns digital models into physical reality.
In 2025, the global Machine Tools Market stands at USD…
More Releases for Monoclonal
Rising Popularity Of Cost-Efficient Biosimilar Monoclonal Antibodies Fuels Monoc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Monoclonal Antibodies (MAbs) Market Through 2025?
The market for monoclonal antibodies (MAbs) has experienced swift expansion in the recent past. The market value is projected to rise from $234.37 billion in 2024 to $261.66 billion in 2025, exhibiting a compound annual growth…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The arthritis monoclonal antibodies…
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02…
Monoclonal Antibody Therapy Market - Empowering the immune system: Monoclonal an …
Newark, New Castle, USA: The "Monoclonal Antibody Therapy Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Monoclonal Antibody Therapy Market: https://www.growthplusreports.com/report/monoclonal-antibody-therapy-market/7736
This latest report researches the industry structure,…
